cerebral atrophy (Lucchinetti et al., 2011; Pirko, Lucchinetti, Sriram, & Bakshi, 2007; Popescu & Lucchinetti, 2012) . Moreover, there are many evidences supporting the correlation between GM damage, measured either as cortical lesion (CL) load or as cortical atrophy, and both physical and cognitive impairment (CI) (Calabrese et al., 2007 Damasceno, Damasceno, & Cendes, 2015; De Stefano et al., 2003; Geurts, Calabrese, Fisher, & Rudick, 2012; Mike et al., 2011; Nelson et al., 2011; Papadopoulou et al., 2013; Roosendaal et al., 2009 ).
Because conventional MRI techniques cannot easily reveal GM lesions, more specific sequences have been introduced, such as double inversion recovery (DIR), which selectively suppresses signal from WM and cerebrospinal fluid (CSF), improving the detection of CLs (Geurts et al., 2005; Turetschek et al., 1998) .
International guidelines have been proposed to facilitate detection of CLs . Moreover, a three-dimensional version (3D-DIR) allows for a shorter acquisition time and a reduction in artefacts (Roosendaal et al., 2009) . With the application of these techniques, several studies have demonstrated that CLs are a typical finding in all phenotypes and stages of MS, including clinically isolated syndrome (CIS) (Calabrese et al., 2007 (Calabrese et al., , 2008 Geurts et al., 2005) and radiologically isolated syndrome (Calabrese & Gallo, 2009; Giorgio et al., 2011) , although they are more represented in the progressive forms and with longer disease duration (Calabrese et al., 2015; Kutzelnigg et al., 2005; Mike et al., 2011; Roosendaal et al., 2009 ).
Cognitive impairment is an important component of MSrelated disability at both the earlier and later stages of the disease, affecting from 40% to 70% of patients with MS. Several cognitive domains, such as long-term memory, attention and concentration, executive functioning, and information processing speed (IPS), may be involved (Amato, Zipoli, & Portaccio, 2006; Chiaravalloti & DeLuca, 2008; Jongen, Ter Horst, & Brands, 2012; Lovera & Kovner, 2012) . In recent years, some MRI studies using DIR sequences have demonstrated a significant correlation between CLs burden, mainly measured as CLs volume, and cognitive dysfunction in patients with MS (Calabrese et al., 2007 Damasceno et al., 2015; Mike et al., 2011; Nelson et al., 2011; Papadopoulou et al., 2013; Roosendaal et al., 2009 ).
Although there is also some evidence of a correlation between regional GM and WM damage measures and performances at neuropsychological tests (Morgen et al., 2006; Nocentini et al., 2014; Sperling et al., 2001) , in our knowledge, there are only sporadic reports of a correlation between regional CLs number and impairment within specific cognitive domains (Roosendaal et al., 2009 ).
With this study, conducted with high-field 3.0 Tesla (T) MRI 3D-DIR sequence, a technique nowadays quite available in the clinical practice setting in Europe, we aimed to investigate the role of CLs load, measured as CLs number, in predicting CI in a cohort of patients affected by relapsing-remitting (RR) and progressive MS. We also analyzed the regional distribution of CLs in the various cerebral lobes and their relative contribution to CI.
| MATERIAL S AND ME THODS

| Patients
We enrolled a group of thirty consecutive patients with MS di- sequences. An even group of consecutive MS patients without CLs (CL−) was enrolled as a control. All individuals were investigated for MS-related CI with specific neuropsychological tests.
Depression was evaluated by the Beck Depression Inventory (BDI) (Hautzinger, 1991) , with regard to the well-known influence of mood disorders on cognitive performance. Patients with severe depression (BDI > 31) were excluded from the study. The study protocol was approved by the "Ethics Committee Province of Parma," and all subjects gave written informed consent prior to participation.
| Image acquisition
All MR images were obtained with a 3.0 T MR scanner (Discovery MR750; GE Healthcare, Milwaukee, WI) equipped with an 8-channel phased-array head coil. We performed 3D fast spin echo (Cube) DIR T2-weighted pulse sequence in order to obtain optimal GM-WM contrast for optimal visualization of cortical MS lesions. This technique is based on 3D-FSE-XETA (eXtended Echo Train Acquisition), an advancement of 3D-FSE in which refocusing flip angle modulation and 2D acceleration enable volumetric coverage with high in-and through-plane resolution within clinical scan times of 3-6 min. Cube DIR sequences were obtained using two adiabatic inversion recovery RF pulses to null the signal from CSF and WM. The TI values for nulling the CSF were set at 3,000-5,000 ms (TIcsf) and WM (TIwm) at 750-800 ms. The Cube DIR sequence parameters were as follows: TE/TR 85/6,900 ms, receiver bandwidth 62.50 kHz, FOV 24 × 24 cm, imaging matrix 256 × 256, section thickness 1.6 mm, 116 sections, NEX 2.0 with parallel imaging acceleration factor 2.0. Intrinsic low SNR was exceeded increasing NEX.
| Image analysis
All images were examined by consensus by two experienced observers (S.G. and G.C.) who were blinded to the patients' identity and clinical features. With regard to the scoring of CLs on DIR images, both examiners followed the recommendations proposed by Geurts et al. (2011) , with particular attention to avoid artefacts. For each patient, total, frontal, temporal, parietal, occipital CLs number, and total T2/FLAIR lesions number were assessed. The different lobes were defined based on anatomic atlas. The scoring was mainly focused on leukocortical and intracortical CLs, because of poor sensitivity of DIR sequences in the detection of subpial lesions . 
| Neuropsychological evaluation
| Statistical analysis
Chi-square test, Student's t test, and median test were used to compare demographic and clinical features between the two groups of patients, with and without CLs at DIR sequences, for categorical and continuous variables, respectively.
To investigate the relationship between MRI and neuropsychological variables, univariate correlations between continuous variables were assessed using the Pearson correlation coefficient.
A multivariate analysis (logistic regression) was performed to determine the relative contribution of demographic (age and gender), clinical (EDSS, disease duration and phenotype), and MRI (total, frontal, temporal, and parietal CLs number and total T2/FLAIR lesions number) variables in predicting the presence of DCI, MCI, and pathologic performance in single BRB tests. We also applied the same multivariate analysis in a subgroup including only patients affected by the RR phenotype.
All statistical analyses were performed using SPSS version 22 (IBM Corp.) statistical package.
| RE SULTS
The total of sixty patients included in the study had the following demographic and clinical features: 42 (70.0%) were women and 18 (30.0%) men; mean age was 39.5 ± 11.13 years (range 18-67 years); mean age at MS onset was 30.7 ± 9.33 years (range 11-54 years); mean disease duration was 101.2 ± 86.87 months (range 2-364 months); median EDSS was 2.0 (range: 1.0-6.5). With regard to disease phenotypes, 47 patients (78.3%) had a RR course, while 13 (21.7%) had a progressive course, eleven secondary progressive (SP), and two primary progressive (PP). Compared to CL− patients, CL+ patients had a greater proportion of progressive forms (p = .03) ( Table 1) .
| Cortical lesions
Among the thirty patients CL+, we found a total of 172 CLs, 83 frontal (48.3%), 57 temporal (33.1%), 31 parietal (18.0%), and a single occipital lesion (0.6%).
In more detail, with regard to the regional pattern of distribution of CLs in CL+ patients, we found that the most affected area was the frontal lobe (22 patients, 73.3%), with a mean burden per patient of 3.8 ± 3.85 lesions (range 1-15), followed by temporal (18 patients, 60.0%), with a mean burden of 3.2 ± 2.90 lesions (range 1-10) per patient, and parietal lobe (18 patients, 60.0%) with a mean burden of 1.7 ± 1.32 lesions (range 1-6) per patient. The occipital lobe was spared in all patients but one.
In Figure 1 , there are some examples of DIR CLs images in our population.
| T2/FLAIR lesions
Considering all our sample, we found a mean value of T2/FLAIR hy- 
| Cognitive impairment
We found DCI, determined by failure in ≥2 BRB tests with scores 2 SD below the mean value score, in 11 patients (18.3%), while MCI, defined by failure in ≥1 BRB test, was present in 24 patients (40.0%).
Analyzing the frequency of CI in the two groups of patients CL+ and CL−, we found a greater proportion of patients with both DCI and MCI in the CL+ group, even though they did not reach the statistical significance (23.3% of CL+ vs 13.3% of CL− patients with DCI, p = .51; 43.3% of CL+ vs 36.7% of CL− patients with MCI, p = .60).
Analyzing the relationship between performance at various BRB tests and CL load, we found a significant correlation between total, frontal, temporal, and parietal CLs number and pathological scores at BRB tests essentially related to memory, attention, and IPS, as shown in Table 2 .
The multivariate (logistic regression) analysis assessing the rela- Table 3 .
The multivariate analysis conducted in the RRMS subgroup (n = 47) demonstrated a significant correlation between total CLs number and SDMT (p = .006). Even total T2/FLAIR lesions number was correlated only with SDMT (p = .001). As for the entire population, even this subgroup analysis revealed only age as independent predictor of DCI (p = .007); age was also correlated with SDMT (p < .001).
| D ISCUSS I ON
In our study, CLs were mainly located in the frontal lobe (48.3%), followed by the temporal (33.1%) and the parietal (18.0%) ones; we found only a single occipital lesion (0.6%) in one patient. Moreover, CLs were more common in the progressive forms (p = .03). These results are consistent with the literature. In fact, the development of CLs has been reported more frequently in the temporal and frontal lobes, while the occipital lobe is less affected (Calabrese, Favaretto, Martini, & Gallo, 2013) . With regard to CLs distribution in different disease subtypes, one recent study reported that in CIS and early RRMS patients, the most affected areas were the fronto-temporal regions, while CLs were more widespread in late RRMS and SPMS (Calabrese et al., 2015) . and subpial and leukocortical CLs were strongly associated with CI in MS (Nielsen et al., 2013) .
In our study, the presence of CLs was more frequent in patients with CI, even though without statistical significance. However, we found a significant correlation between total, frontal, temporal, and parietal CLs number and pathological performances at BRB tests mainly related to memory, attention, and the most affected cognitive domains in MS. The multivariate analysis confirmed the correlation between total CLs number and the presence of MCI or pathologic score at PASAT 3 and ST. The logistic regression analysis conducted on the RRMS subgroup found results similar to that conducted in all sample, with a significant correlation between total CLs and SDMT, a test which explores mainly IPS, as PASAT 3.
In the interpretation of these results, we have to consider several limitations presented by our study. First, the size of our sample was probably too limited and the "matching" of the two groups too incomplete to allow definitive conclusions. It is likely, in fact, that the lack of a statistically significant correlation between CLs and CI is mainly due to this reason. We had also to consider the lack of a control group well matched to the patients. Secondly, the MRI technique we employed, that is 3D-DIR, is far from perfect in detecting total CLs burden. A histopathological MRI study describing the TA B L E 3 Logistic regression analysis including demographic, clinical, and MRI variables significantly correlated with DCI, MCI, or impairment in single BRB tests postmortem verification of MS CLs detection with 3D-DIR reported a high sensitivity for mixed GM-WM lesions (83%), but only 18% for intracortical lesions (Seewann et al., 2012) . In addition to that, we have to consider that subpial CLs, which are also associated with physical and cognitive dysfunction in patients with MS, are poorly detected by conventional MRI and even DIR . However, other comparative neuropathological and imaging studies demonstrated that the number of CLs detected at MRI correlates well with their total number revealed by histology, concluding that "the tip of the iceberg detected by MRI and its bulk differ only in size." (Calabrese et al., 2013; Geurts et al., 2012; Seewann et al., 2011) Then, there are some consensus recommendations for MS CLs scoring using DIR MRI (Daams et al., 2016) .
In spite of these limitations, our study confirmed the correlation between total CLs number and low performances in several cognitive tests which explore memory, attention, and IPS, as shown in previous studies Mike et al., 2011; Nelson et al., 2011; Roosendaal et al., 2009 ). Moreover, we found this correlation also with CLs number detected in single cerebral lobes, with the exception of the occipital one, where we found only one lesion. In our knowledge, there are only sporadic reports in the literature of a direct correlation between regional CLs number and deficit in specific neuropsychological tests, such as one study describing the association between hippocampal lesion number and visuospatial memory (Roosendaal et al., 2009 ). Besides, some previous studies described the relationship between regional GM atrophy and cognition (Morgen et al., 2006; Nocentini et al., 2014) ; another study, instead, reported a correlation between frontal and parietal WM lesions volume and impairment on neuropsychological tests evaluating sustained attention, processing speed, and verbal memory (Sperling et al., 2001) . Also, our data reported an association between single BRB tests and CLs number detected in various cerebral lobes, according to the aforementioned studies. This lack of anatomic specificity could be explained by the involvement of different cognitive functions associated with several cortical areas during the performance of a single test (Nocentini et al., 2014 However, large MRI longitudinal studies are needed to explore in detail these implications. We also need to develop more sensitive MRI technologies to increase our capacity to investigate cortical pathology in MS and its complex interaction with GM and WM damage in the determination of MS-related CI.
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